lanthanum hydroxide has been researched along with Kidney Failure, Chronic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| An, M; Bu, R; Cao, X; Gao, J; Gao, Y; Gu, C; Guo, M; Han, R; Hao, J; Li, B; Li, G; Liu, H; Liu, Y; Meng, Y; Su, C; Sun, L | 1 |
| Jiang, M; Wan, T; Wang, Y; Xu, C; Zheng, H | 1 |
| Li, G; Liu, D; Ma, Z; Miao, X; Wu, Y; Xing, H; Yu, T; Zhang, X | 1 |
1 review(s) available for lanthanum hydroxide and Kidney Failure, Chronic
| Article | Year |
|---|---|
Meta-Analysis Treatment Hyperphosphatemia Chronic Renal Failure Based on Nano Lanthanum Hydroxide.
Topics: Calcium; Humans; Hydroxides; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Phosphates; Phosphorus; Renal Dialysis; Treatment Outcome | 2020 |
2 other study(ies) available for lanthanum hydroxide and Kidney Failure, Chronic
| Article | Year |
|---|---|
Metabolomics of clinical samples reveal the treatment mechanism of lanthanum hydroxide on vascular calcification in chronic kidney disease.
Topics: Amino Acid Transport Systems, Neutral; Humans; Kidney Failure, Chronic; Lanthanum; Metabolomics; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Renal Insufficiency, Chronic; TOR Serine-Threonine Kinases; Vascular Calcification | 2022 |
Nano-lanthanum hydroxide, a novel phosphate binder, for treating hyperphosphatemia: A preclinical study.
Topics: Animals; Drug Evaluation, Preclinical; Female; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Male; Mice; Nanoparticles; Phosphates; Rats; Rats, Wistar | 2019 |